Detalles de la búsqueda
1.
PMP22 duplication dysregulates lipid homeostasis and plasma membrane organization in developing human Schwann cells.
Brain
; 2024 May 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-38743588
2.
Therapeutic Intervention with Anti-Complement Component 5 Antibody Does Not Reduce NASH but Does Attenuate Atherosclerosis and MIF Concentrations in Ldlr-/-.Leiden Mice.
Int J Mol Sci
; 23(18)2022 Sep 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-36142647
3.
tRNA splicing endonuclease mutations cause pontocerebellar hypoplasia.
Nat Genet
; 40(9): 1113-8, 2008 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-18711368
4.
Inhibition of the membrane attack complex of the complement system reduces secondary neuroaxonal loss and promotes neurologic recovery after traumatic brain injury in mice.
J Immunol
; 192(5): 2339-48, 2014 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-24489093
5.
M. leprae components induce nerve damage by complement activation: identification of lipoarabinomannan as the dominant complement activator.
Acta Neuropathol
; 129(5): 653-67, 2015 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-25772973
6.
A frameshift mutation in LRSAM1 is responsible for a dominant hereditary polyneuropathy.
Hum Mol Genet
; 21(2): 358-70, 2012 Jan 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-22012984
7.
Aberrant expression of miR-218 and miR-204 in human mesial temporal lobe epilepsy and hippocampal sclerosis-convergence on axonal guidance.
Epilepsia
; 55(12): 2017-27, 2014 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-25410734
8.
Glucocorticoid-induced changes in gene expression of airway smooth muscle in patients with asthma.
Am J Respir Crit Care Med
; 187(10): 1076-84, 2013 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-23491407
9.
Impairment of the tRNA-splicing endonuclease subunit 54 (tsen54) gene causes neurological abnormalities and larval death in zebrafish models of pontocerebellar hypoplasia.
Hum Mol Genet
; 20(8): 1574-84, 2011 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-21273289
10.
Tackling Neuroinflammation After Traumatic Brain Injury: Complement Inhibition as a Therapy for Secondary Injury.
Neurotherapeutics
; 20(1): 284-303, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36222978
11.
The systemic inhibition of the terminal complement system reduces neuroinflammation but does not improve motor function in mouse models of CMT1A with overexpressed PMP22.
Curr Res Neurobiol
; 4: 100077, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36926597
12.
Corrigendum: Ldlr-/-.Leiden mice develop neurodegeneration, age-dependent astrogliosis and obesity-induced changes in microglia immunophenotype which are partly reversed by complement component 5 neutralizing antibody.
Front Cell Neurosci
; 17: 1267913, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37614912
13.
Ldlr-/-.Leiden mice develop neurodegeneration, age-dependent astrogliosis and obesity-induced changes in microglia immunophenotype which are partly reversed by complement component 5 neutralizing antibody.
Front Cell Neurosci
; 17: 1205261, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37457817
14.
Activation of Toll-like receptor, RAGE and HMGB1 signalling in malformations of cortical development.
Brain
; 134(Pt 4): 1015-32, 2011 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-21414994
15.
Development, Characterization, and in vivo Validation of a Humanized C6 Monoclonal Antibody that Inhibits the Membrane Attack Complex.
J Innate Immun
; : 1-21, 2022 May 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-35551129
16.
Silencing the expression of Ras family GTPase homologues decreases inflammation and joint destruction in experimental arthritis.
Am J Pathol
; 177(6): 3010-24, 2010 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-20971740
17.
Safety and efficacy of C1-inhibitor in traumatic brain injury (CIAO@TBI): study protocol for a randomized, placebo-controlled, multi-center trial.
Trials
; 22(1): 874, 2021 Dec 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-34863258
18.
Induction of sodium channel Na(x) (SCN7A) expression in rat and human hippocampus in temporal lobe epilepsy.
Epilepsia
; 51(9): 1791-800, 2010 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-20738386
19.
The therapeutic potential of LNA-modified siRNAs: reduction of off-target effects by chemical modification of the siRNA sequence.
Methods Mol Biol
; 487: 189-203, 2009.
Artículo
en Inglés
| MEDLINE | ID: mdl-19301648
20.
Evaluation of locked nucleic acid-modified small interfering RNA in vitro and in vivo.
Mol Cancer Ther
; 6(3): 833-43, 2007 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-17363479